Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10652047rdf:typepubmed:Citationlld:pubmed
pubmed-article:10652047lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:10652047lifeskim:mentionsumls-concept:C0022671lld:lifeskim
pubmed-article:10652047lifeskim:mentionsumls-concept:C0029453lld:lifeskim
pubmed-article:10652047lifeskim:mentionsumls-concept:C0043603lld:lifeskim
pubmed-article:10652047lifeskim:mentionsumls-concept:C1708528lld:lifeskim
pubmed-article:10652047pubmed:issue2lld:pubmed
pubmed-article:10652047pubmed:dateCreated2000-3-9lld:pubmed
pubmed-article:10652047pubmed:abstractTextVery rapid bone loss, osteopenia and skeletal morbidity after renal transplantation have been well documented and found to occur in a sex dependent fashion. Glucocorticoids, cyclosporine and pre-existing uremic osteodystrophy have been implicated in the pathogenesis of the skeletal lesions. Glucocorticoid induced osteopenia is also a serious clinical problem in patients with various nonrenal diseases and can be prevented, or at least attenuated, by pamidronate and other bisphosphonates.lld:pubmed
pubmed-article:10652047pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:languageenglld:pubmed
pubmed-article:10652047pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:citationSubsetIMlld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10652047pubmed:statusMEDLINElld:pubmed
pubmed-article:10652047pubmed:monthFeblld:pubmed
pubmed-article:10652047pubmed:issn0085-2538lld:pubmed
pubmed-article:10652047pubmed:authorpubmed-author:EvansKKlld:pubmed
pubmed-article:10652047pubmed:authorpubmed-author:CunninghamJJlld:pubmed
pubmed-article:10652047pubmed:authorpubmed-author:DixM RMRlld:pubmed
pubmed-article:10652047pubmed:authorpubmed-author:BallEElld:pubmed
pubmed-article:10652047pubmed:authorpubmed-author:AlmondM KMKlld:pubmed
pubmed-article:10652047pubmed:issnTypePrintlld:pubmed
pubmed-article:10652047pubmed:volume57lld:pubmed
pubmed-article:10652047pubmed:ownerNLMlld:pubmed
pubmed-article:10652047pubmed:authorsCompleteYlld:pubmed
pubmed-article:10652047pubmed:pagination684-90lld:pubmed
pubmed-article:10652047pubmed:dateRevised2008-1-28lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:meshHeadingpubmed-meshheading:10652047...lld:pubmed
pubmed-article:10652047pubmed:year2000lld:pubmed
pubmed-article:10652047pubmed:articleTitlePamidronate therapy as prevention of bone loss following renal transplantation.lld:pubmed
pubmed-article:10652047pubmed:affiliationDepartment of Renal Medicine and Transplantation, The Royal London Hospital, London, England, United Kingdom.lld:pubmed
pubmed-article:10652047pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10652047pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10652047pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652047lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10652047lld:pubmed